Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Adult paratesticular rhabdomyosarcoma

Nature Clinical Practice Urology volume 2, pages 398–402 (2005)Cite this article

Abstract

Background A 29-year-old male patient presented with a history of painless enlargement of the left hemiscrotum.

Investigations Laboratory tests for β-human chorionic gonadotrophin, α-fetoprotein, and lactate dehydrogenase, physical examination, and CT of the chest, abdomen and pelvis. Histologic examination, nerve-sparing retroperitoneal lymph-node dissection.

Diagnosis Paratesticular rhabdomyosarcoma with lymph node metastasis.

Management Inguinal radical orchiectomy and adjuvant chemotherapy for 48 weeks. Radiotherapy and additional chemotherapy were administered following local recurrence.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Histologic findings of the resected tumor.
Figure 2: Macroscopic view of the left retroperitoneal lymph node, resected prior to chemotherapy, mapped on the schema of major vessels and ureters.
Figure 3: Treatment schema for Intergroup Rhabdomyosarcoma Study IRS-III chemotherapy regimen 36

References

  1. Walterhouse DO et al. (2001) Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group. Cancer 92: 3135–3146

    Article  CAS  Google Scholar 

  2. Hermans BP et al. (1998) Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma? J Urol 160: 2074–2077

    Article  CAS  Google Scholar 

  3. Ferrari A and Casanova M (2005) Current chemotherapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 5: 283–294

    Article  CAS  Google Scholar 

  4. Crist W et al. (1995) The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13: 610–630

    Article  CAS  Google Scholar 

  5. Weiss SW and Goldblum JR (2001) Rhabdomyosarcoma. In Enzinger and Weiss's Soft Tissue Tumors, 785–835 (Eds Weiss SW and Goldblum JR) St. Louis: CV Mosby

    Google Scholar 

  6. Ferrari A et al. (2003) Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98: 571–580

    Article  Google Scholar 

  7. Baker KS et al. (2000) Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 18: 2427–2434

    Article  CAS  Google Scholar 

  8. Ferrari A et al. (2002) Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. J Clin Oncol 20: 449–455

    Article  CAS  Google Scholar 

  9. Walterhouse DO et al. (2004) Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study. J Clin Oncol 22: 1398–1403

    Article  CAS  Google Scholar 

  10. Breneman JC et al. (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21: 78–84

    Article  Google Scholar 

  11. LaQuaglia MP et al. (1989) Mortality in pediatric paratesticular rhabdomyosarcoma: a multivariate analysis. J Urol 142: 473–478

    Article  CAS  Google Scholar 

  12. Crist WM et al. (2001) Intergroup rhabdomyosarcoma study IV: results for patients with nonmetastatic disease. J Clin Oncol 19: 3091–3102

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Fellow of Urology at the Hokkaido Cancer Center, and is now a Research Fellow at the Geffen Medical School at the University of California, Los Angeles, CA, USA

    Kazunori Haga

  2. Staff Urologist at the Hokkaido Cancer Center,

    Akira Kashiwagi

  3. Instructor of Urology at Hokkaido University, Japan

    Akira Kashiwagi

  4. Chief of Urology at the Hokkaido Cancer Center,

    Satoshi Nagamori

  5. Instructor of Urology at Hokkaido University, Japan

    Satoshi Nagamori

  6. Chief of Pathology at the Hokkaido Cancer Center, Japan

    Katushige Yamashiro

Authors
  1. Kazunori Haga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akira Kashiwagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satoshi Nagamori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katushige Yamashiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazunori Haga.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haga, K., Kashiwagi, A., Nagamori, S. et al. Adult paratesticular rhabdomyosarcoma. Nat Rev Urol 2, 398–402 (2005). https://doi.org/10.1038/ncpuro0257

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0257

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing